Development of a Clinical Photographic Atlas for Skin Aging Based on the Characterization of Facial Dermal Collagen Using LC-OCT Technology

NCT07409675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-02-13

No results posted yet for this study

Summary

This is a single-center, single visit study conducted in healthy female subjects, aged 20 to 75 years inclusive meeting specific inclusion/exclusion criteria. The study is to develop a clinical photographic atlas to assess skin aging by studying the relationship between age, sun exposure and quantity of collagen measured non-invasively (LC-OCT). No product will be tested during the study.

Conditions

  • Healthy Subjects
  • Healthy Adult

Interventions

DIAGNOSTIC_TEST

LC-OCT acquisitions on the forehead

During the study visit, the investigator will for each subjects in Group 1: \- Perform standardized photographs using the ColorFace Group 2: \- Perform standardized photographs using the ColorFace Group 3: \- Perform standardized photographs using the ColorFace Group 4: * Perform standardized photographs using the ColorFace * Perform LC-OCT acquisitions on the forehead Group 5: * Perform standardized photographs using the ColorFace®; * Perform LC-OCT acquisitions on the forehead

DEVICE

Perform standardized photographs using ColorFace

Photographs

DEVICE

LC-OCT acquisitions on forehead

Image acquisition

DEVICE

Perform photo-shooting using smartphones

photo from back and front camera pictures and selfie

Sponsors & Collaborators

  • Centre de Pharmacologie Clinique Applique a la Dermatologie

    collaborator OTHER
  • Vichy Laboratoires

    lead INDUSTRY

Principal Investigators

  • Catherine QUEILLE-ROUSSEL, MD · CPCAD, Hôpital l'Archet 2

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-06
Primary Completion
2025-02-19
Completion
2025-02-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07409675 on ClinicalTrials.gov